ArticleTherapeutic advances in musculoskeletal disease2023

The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2.

Atul Deodhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.